Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury

Hidaka Kono, Ken Nakagawa, Shinya Morita, Kazunobu Shinoda, Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima, Kazuo Umezawa, Mototsugu Oya

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background. In kidney transplantation, the relationship between prolonged warm or cold ischemic storage of kidneys and a higher incidence of delayed graft function is previously known, and delayed graft function has been known to aggravate poor long-term graft survival. We investigated the effect of a novel nuclear factor-JB activation inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on renal ischemia-reperfusion (I/R) injury. Methods. DHMEQ was administered to Lewis rats once just before renal artery clamping (DHMEQ pretreatment group), and the effect on I/R injury was investigated. Results. In the DHMEQ pretreatment group, the 24-hr urine volume on days 1 to 3 after I/R was significantly larger, and the protein concentration of the urine on days 2 to 7 was significantly smaller than in the untreated group. The serum creatinine level was significantly improved, and significantly lower levels of the inflammatory cells and inflammatory cytokines were present in the kidneys on day 1. The relative ratio of nuclear to cytoplasmic nuclear factor-JB and oxidative stress of kidney tissue on day 1 were significantly decreased. Conclusions. Treatment with DHMEQ before renal artery clamping may therefore be useful for renal I/R injury and application to renal transplantation is expected.

Original languageEnglish
Pages (from-to)863-870
Number of pages8
JournalTransplantation
Volume96
Issue number10
DOIs
Publication statusPublished - 2013

Fingerprint

Reperfusion Injury
Kidney
Delayed Graft Function
Renal Artery
Constriction
Kidney Transplantation
Urine
Graft Survival
Reperfusion
Creatinine
Oxidative Stress
Ischemia
dehydroxymethylepoxyquinomicin
Cytokines
Incidence
Serum
Proteins
Therapeutics

Keywords

  • Nuclear factor-kB
  • Renal ischemia-reperfusion injury
  • Tubular necrosis

ASJC Scopus subject areas

  • Transplantation

Cite this

Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury. / Kono, Hidaka; Nakagawa, Ken; Morita, Shinya; Shinoda, Kazunobu; Mizuno, Ryuichi; Kikuchi, Eiji; Miyajima, Akira; Umezawa, Kazuo; Oya, Mototsugu.

In: Transplantation, Vol. 96, No. 10, 2013, p. 863-870.

Research output: Contribution to journalArticle

Kono, Hidaka ; Nakagawa, Ken ; Morita, Shinya ; Shinoda, Kazunobu ; Mizuno, Ryuichi ; Kikuchi, Eiji ; Miyajima, Akira ; Umezawa, Kazuo ; Oya, Mototsugu. / Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury. In: Transplantation. 2013 ; Vol. 96, No. 10. pp. 863-870.
@article{f87013e5f055434c84b5dab521a52924,
title = "Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury",
abstract = "Background. In kidney transplantation, the relationship between prolonged warm or cold ischemic storage of kidneys and a higher incidence of delayed graft function is previously known, and delayed graft function has been known to aggravate poor long-term graft survival. We investigated the effect of a novel nuclear factor-JB activation inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on renal ischemia-reperfusion (I/R) injury. Methods. DHMEQ was administered to Lewis rats once just before renal artery clamping (DHMEQ pretreatment group), and the effect on I/R injury was investigated. Results. In the DHMEQ pretreatment group, the 24-hr urine volume on days 1 to 3 after I/R was significantly larger, and the protein concentration of the urine on days 2 to 7 was significantly smaller than in the untreated group. The serum creatinine level was significantly improved, and significantly lower levels of the inflammatory cells and inflammatory cytokines were present in the kidneys on day 1. The relative ratio of nuclear to cytoplasmic nuclear factor-JB and oxidative stress of kidney tissue on day 1 were significantly decreased. Conclusions. Treatment with DHMEQ before renal artery clamping may therefore be useful for renal I/R injury and application to renal transplantation is expected.",
keywords = "Nuclear factor-kB, Renal ischemia-reperfusion injury, Tubular necrosis",
author = "Hidaka Kono and Ken Nakagawa and Shinya Morita and Kazunobu Shinoda and Ryuichi Mizuno and Eiji Kikuchi and Akira Miyajima and Kazuo Umezawa and Mototsugu Oya",
year = "2013",
doi = "10.1097/TP.0b013e3182a3df74",
language = "English",
volume = "96",
pages = "863--870",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Effect of a novel nuclear factor-jb activation inhibitor on renal ischemia-reperfusion injury

AU - Kono, Hidaka

AU - Nakagawa, Ken

AU - Morita, Shinya

AU - Shinoda, Kazunobu

AU - Mizuno, Ryuichi

AU - Kikuchi, Eiji

AU - Miyajima, Akira

AU - Umezawa, Kazuo

AU - Oya, Mototsugu

PY - 2013

Y1 - 2013

N2 - Background. In kidney transplantation, the relationship between prolonged warm or cold ischemic storage of kidneys and a higher incidence of delayed graft function is previously known, and delayed graft function has been known to aggravate poor long-term graft survival. We investigated the effect of a novel nuclear factor-JB activation inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on renal ischemia-reperfusion (I/R) injury. Methods. DHMEQ was administered to Lewis rats once just before renal artery clamping (DHMEQ pretreatment group), and the effect on I/R injury was investigated. Results. In the DHMEQ pretreatment group, the 24-hr urine volume on days 1 to 3 after I/R was significantly larger, and the protein concentration of the urine on days 2 to 7 was significantly smaller than in the untreated group. The serum creatinine level was significantly improved, and significantly lower levels of the inflammatory cells and inflammatory cytokines were present in the kidneys on day 1. The relative ratio of nuclear to cytoplasmic nuclear factor-JB and oxidative stress of kidney tissue on day 1 were significantly decreased. Conclusions. Treatment with DHMEQ before renal artery clamping may therefore be useful for renal I/R injury and application to renal transplantation is expected.

AB - Background. In kidney transplantation, the relationship between prolonged warm or cold ischemic storage of kidneys and a higher incidence of delayed graft function is previously known, and delayed graft function has been known to aggravate poor long-term graft survival. We investigated the effect of a novel nuclear factor-JB activation inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on renal ischemia-reperfusion (I/R) injury. Methods. DHMEQ was administered to Lewis rats once just before renal artery clamping (DHMEQ pretreatment group), and the effect on I/R injury was investigated. Results. In the DHMEQ pretreatment group, the 24-hr urine volume on days 1 to 3 after I/R was significantly larger, and the protein concentration of the urine on days 2 to 7 was significantly smaller than in the untreated group. The serum creatinine level was significantly improved, and significantly lower levels of the inflammatory cells and inflammatory cytokines were present in the kidneys on day 1. The relative ratio of nuclear to cytoplasmic nuclear factor-JB and oxidative stress of kidney tissue on day 1 were significantly decreased. Conclusions. Treatment with DHMEQ before renal artery clamping may therefore be useful for renal I/R injury and application to renal transplantation is expected.

KW - Nuclear factor-kB

KW - Renal ischemia-reperfusion injury

KW - Tubular necrosis

UR - http://www.scopus.com/inward/record.url?scp=84891832773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891832773&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3182a3df74

DO - 10.1097/TP.0b013e3182a3df74

M3 - Article

C2 - 23958925

AN - SCOPUS:84891832773

VL - 96

SP - 863

EP - 870

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -